Cargando…
Response to comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
Early in the SARS-CoV-2 pandemic, we compared transcriptome data from hospitalized COVID-19 patients and control patients without COVID-19. We found changes in procoagulant and fibrinolytic gene expression in the lungs of COVID-19 patients (Mast et al., 2021). These findings have been challenged bas...
Autores principales: | Mast, Alan E, Wolberg, Alisa S, Gailani, David, Garvin, Michael R, Alvarez, Christiane, Miller, J Izaak, Jones, Piet, Aronow, Bruce, Jacobson, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752086/ https://www.ncbi.nlm.nih.gov/pubmed/35014952 http://dx.doi.org/10.7554/eLife.74951 |
Ejemplares similares
-
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
por: Mast, Alan E, et al.
Publicado: (2021) -
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
por: Garvin, Michael R, et al.
Publicado: (2020) -
Comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
por: FitzGerald, Ethan S, et al.
Publicado: (2022) -
Response to comment on 'Valid molecular dynamics simulations of human hemoglobin require a surprisingly large box size'
por: El Hage, Krystel, et al.
Publicado: (2019) -
Interrogating theoretical models of neural computation with emergent property inference
por: Bittner, Sean R, et al.
Publicado: (2021)